Skip to main content
NVDA-0.82%AAPL+0.91%GOOGL-2.28%MSFT-0.15%AMZN+0.01%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.43%TSLA-1.41%SKHY+7.05%MU-2.00%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.20%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-1.52%0005.HK-0.78%HSBA.L-1.48%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.19%CHFJPY-1.57%AUDJPY-1.53%USDJPY-1.32%EURJPY-1.29%GBPJPY-1.24%CADJPY-1.17%NZDCAD-1.04%GBPNZD+0.95%EURNZD+0.93%NZDUSD-0.90%USDNOK+0.70%AUDNZD+0.69%NZDCHF-0.66%USDZAR+0.58%EURNOK+0.54%USDSEK+0.49%CHFNOK+0.49%EURZAR+0.44%GBPZAR+0.43%GBPTRY+0.41%AUDCAD-0.38%CADCHF+0.38%EURSEK+0.34%GBPHKD+0.32%GBPCHF+0.31%USDTHB+0.30%USDPLN+0.29%GBPMXN-0.28%CHFSEK+0.28%AUDNOK+0.28%NOKJPY-0.28%GBPAUD+0.27%EURCHF+0.27%AUDDKK-0.27%USDCHF+0.26%SGDJPY+0.26%AUDSGD-0.25%EURAUD+0.24%USDMXN+0.23%AUDUSD-0.22%EURHKD-0.16%USDSGD+0.16%USDILS+0.16%USDDKK+0.15%EURPLN+0.14%USDCAD-0.13%EURCAD-0.13%PLNJPY+0.12%USDTRY+0.11%EURCNH-0.11%GBPCAD-0.09%GBPUSD+0.07%EURCZK-0.07%CHFSGD-0.05%NZDMXN+0.04%AUDCHF+0.04%USDCOP-0.04%EURGBP-0.03%USDCNH+0.02%EURUSD+0.02%EURSGD+0.01%USDHKD+0.01%NZDSGD-0.01%EURDKK0.00%GBPSGD0.00%HG1-4.14%XPTUSD-3.57%COFFEE-2.51%XAGUSD-2.50%GAGUSD-2.50%SUGAR+2.02%USOIL+1.91%UKOIL+1.87%COCOA-1.11%COTTON+0.84%C1+0.76%S1+0.75%BTCUSD-0.64%ETHUSD-0.36%USDTUSD-0.04%XRPUSD-1.35%SOLUSD-0.47%TRXUSDT+0.45%ZECUSDT-2.14%DOGEUSD-1.16%XMRUSDT-1.11%LINKUSD+0.14%XLMUSD-0.97%BCHUSDT-2.64%LTCUSD-1.86%UNIUSD-2.16%TONUSD+24.88%HBARUSDT-1.07%SUIUSD-1.42%TAOUSDT-1.32%AAVEUSD-2.27%DOTUSDT-2.36%ICPUSDT-1.04%ONDOUSDT-2.01%WLDUSDT-1.71%ATOMUSDT-3.30%ARBUSDT-0.98%JUPUSDT-2.53%INJUSDT-2.31%STXUSDT-2.34%FETUSDT-2.68%TIAUSDT-0.34%PYTHUSDT-0.46%SEIUSDT-3.91%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-3.07%OPUSDT-0.99%POLUSDT-5.30%IOTAUSDT-2.98%AXSUSDT-1.82%FARTCOINUSDT-2.90%EOSUSDT-0.06%DYDXUSDT+0.65%ORDIUSDT-0.28%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%NVDA-0.82%AAPL+0.91%GOOGL-2.28%MSFT-0.15%AMZN+0.01%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.43%TSLA-1.41%SKHY+7.05%MU-2.00%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.20%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-1.52%0005.HK-0.78%HSBA.L-1.48%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.19%CHFJPY-1.57%AUDJPY-1.53%USDJPY-1.32%EURJPY-1.29%GBPJPY-1.24%CADJPY-1.17%NZDCAD-1.04%GBPNZD+0.95%EURNZD+0.93%NZDUSD-0.90%USDNOK+0.70%AUDNZD+0.69%NZDCHF-0.66%USDZAR+0.58%EURNOK+0.54%USDSEK+0.49%CHFNOK+0.49%EURZAR+0.44%GBPZAR+0.43%GBPTRY+0.41%AUDCAD-0.38%CADCHF+0.38%EURSEK+0.34%GBPHKD+0.32%GBPCHF+0.31%USDTHB+0.30%USDPLN+0.29%GBPMXN-0.28%CHFSEK+0.28%AUDNOK+0.28%NOKJPY-0.28%GBPAUD+0.27%EURCHF+0.27%AUDDKK-0.27%USDCHF+0.26%SGDJPY+0.26%AUDSGD-0.25%EURAUD+0.24%USDMXN+0.23%AUDUSD-0.22%EURHKD-0.16%USDSGD+0.16%USDILS+0.16%USDDKK+0.15%EURPLN+0.14%USDCAD-0.13%EURCAD-0.13%PLNJPY+0.12%USDTRY+0.11%EURCNH-0.11%GBPCAD-0.09%GBPUSD+0.07%EURCZK-0.07%CHFSGD-0.05%NZDMXN+0.04%AUDCHF+0.04%USDCOP-0.04%EURGBP-0.03%USDCNH+0.02%EURUSD+0.02%EURSGD+0.01%USDHKD+0.01%NZDSGD-0.01%EURDKK0.00%GBPSGD0.00%HG1-4.14%XPTUSD-3.57%COFFEE-2.51%XAGUSD-2.50%GAGUSD-2.50%SUGAR+2.02%USOIL+1.91%UKOIL+1.87%COCOA-1.11%COTTON+0.84%C1+0.76%S1+0.75%BTCUSD-0.64%ETHUSD-0.36%USDTUSD-0.04%XRPUSD-1.35%SOLUSD-0.47%TRXUSDT+0.45%ZECUSDT-2.14%DOGEUSD-1.16%XMRUSDT-1.11%LINKUSD+0.14%XLMUSD-0.97%BCHUSDT-2.64%LTCUSD-1.86%UNIUSD-2.16%TONUSD+24.88%HBARUSDT-1.07%SUIUSD-1.42%TAOUSDT-1.32%AAVEUSD-2.27%DOTUSDT-2.36%ICPUSDT-1.04%ONDOUSDT-2.01%WLDUSDT-1.71%ATOMUSDT-3.30%ARBUSDT-0.98%JUPUSDT-2.53%INJUSDT-2.31%STXUSDT-2.34%FETUSDT-2.68%TIAUSDT-0.34%PYTHUSDT-0.46%SEIUSDT-3.91%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-3.07%OPUSDT-0.99%POLUSDT-5.30%IOTAUSDT-2.98%AXSUSDT-1.82%FARTCOINUSDT-2.90%EOSUSDT-0.06%DYDXUSDT+0.65%ORDIUSDT-0.28%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%
MK

Merck KGaA (MRKd)

FRA • Healthcare

€132.17
-€0.52 (-0.4%)
Market open

September 10, 2026 at 12:12 UTC

Open€133.4
Previous Close€132.7
Day Range€130.65 - €133.7
Avg. Volume (3M)213.1K
Market Cap€57.3B
P/E Ratio24.3
52 Week Range
€100.7€148.8

Interactive Chart

12:12:24 UTC

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned€5.4B100%
Gross Profitminus cost of goods€3.1B58%
Operating Incomeminus R&D and overhead€1.1B22%
Net Incomeminus taxes and the rest€490M9%

In plain terms: out of every €100 in revenue, Merck KGaA keeps €9 as net profit.

Fundamentals & Financials

Revenue (TTM)
€21.1B
Net Income (TTM)
€2.3B
EPS (TTM)
€5.45
ROA (TTM)
4.5%
Current Ratio
1.69
Dividend Yield
1.6%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

€1.08Q2 2019
€0.79Q3 2019
€0.73Q4 2019

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2019

Merck KGaA topped consensus on both EPS and revenue in the second fiscal quarter of 2026, reported Aug. 6, with adjusted EPS of EUR 2.14 against a EUR 2.00 estimate, +7.0%, and revenue of EUR 5.434 billion against a EUR 5.290 billion estimate, +2.7%. Revenue rose about 3% from EUR 5.255 billion a year ago, while gross margin came in near 58% and operating margin around 22% as operating income reached about EUR 1.2 billion. Net income fell about 25% to roughly EUR 490 million from EUR 652 million a year earlier, and operating cash flow was about EUR 605 million. Consensus for the next period calls for EPS of EUR 2.07 on revenue of EUR 5.383 billion.

View full earnings history

About Merck KGaA

Merck KGaA trades on XETRA under MRK.DE and operates as a healthcare company with prescription medicines at its core, alongside laboratory and industrial supplies and electronic materials. In FY2025, it generated EUR 21.1 billion in revenue. The company is a subsidiary of E. Merck KG.

Name
Merck KGaA
CEO
Kai Beckmann
Website
www.emdgroup.com
Industry
Healthcare
Year Founded
1668
Employees
62,136

Today's Snapshot

AI-generated

So far today, MRKd is trading slightly lower at 132.10, in line with a flat sector.

Trading Volume

Below 10d avg (199.6K)

23K

vs S&P 500 Today

Inline with Market

+0.03%

Updated: September 10, 2026 at 10:33 UTC

MRKd Headlines

Merck KGaA to buy Bio-Techne for $11.3 billion

June 25, 2026

3 min read

AI Stock Bubble Concerns Trigger Broad Market Sell-Off

November 18, 2025

5 min read
View All News

Technical Indicators

2 Buy1 Neutral5 Sell
MRKd exhibits a sell stance driven by weakening momentum and negative trend signals, with MACD and a deep CCI shortfall weighing on the picture while RSI hovers near oversold. The price sits below short- and medium-term moving averages but remains above the 200-day level, so the longer-term trend is less bearish even as on-balance volume is not supportive. ADX indicates only a modest trend and ATR shows limited intraday range, while Bollinger readings suggest proximity to the lower band. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$127.74 - $137.60
    Sell
  • RSI (14)30.36
    Neutral
  • Stochastic %K (14, 3, 3)11.42
    Buy
  • MACD Level (12, 26)-1.59
    Sell

Peers & Related Assets

BAYNdBayer Aktiengesellschaft
€48.78-1.0%
SHLdSiemens Healthineers AG
€38.72+0.1%
FREdFresenius SE & Co. KGaA
€44.56+0.5%
BRM.DEBristol-Myers Squibb Company
CGN.DECigna Corporation
SHL.DESiemens Healthineers AG
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.